Acadia Healthcare Company, Inc. (ACHC) — SEC Filings
Acadia Healthcare Company, Inc. (ACHC) — 41 SEC filings. Latest: ARS (Mar 25, 2026). Includes 19 8-K, 9 SC 13G/A, 6 10-Q.
View Acadia Healthcare Company, Inc. on SEC EDGAR
Overview
Acadia Healthcare Company, Inc. (ACHC) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a ARS filed on Mar 25, 2026: Acadia Healthcare Company, Inc. (CIK: 0001520697) filed its Annual Report to Security Holders (Form ARS) on March 25, 2026, for the fiscal year ending December 31, 2025. This routine filing provides shareholders with the company's annual financial and operational overview, which is crucial for under
Sentiment Summary
Across 41 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 38 neutral, 1 mixed. The dominant filing sentiment for Acadia Healthcare Company, Inc. is neutral.
Filing Type Overview
Acadia Healthcare Company, Inc. (ACHC) has filed 1 ARS, 1 DEFA14A, 19 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 9 SC 13G/A, 1 SC 13G with the SEC between Jan 2024 to Mar 2026.
Filings by Year
Recent SEC Filings (41)
Risk Profile
Risk Assessment: Of ACHC's 29 recent filings, 1 were flagged as high-risk, 9 as medium-risk, and 19 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $2.49B |
| Net Income | $74.7M |
| EPS | $0.82 |
| Total Assets | $6.41B |
| Total Debt | $2.28B |
Key Executives
- Inman Litigation
- Christopher H. Hunter
- Abigail P. Johnson
Industry Context
Acadia Healthcare operates within the behavioral health and addiction treatment sector, a growing but highly regulated industry. Demand for services is driven by increasing awareness of mental health issues and substance use disorders, alongside evolving insurance coverage. However, the sector faces challenges related to workforce shortages, reimbursement rate pressures from government and commercial payers, and intense competition from both large national providers and smaller regional facilities.
Top Tags
healthcare (6) · 8-k (5) · corporate-governance (4) · 10-Q (4) · institutional-ownership (4) · filing (3) · financials (3) · financial-results (3) · debt (3) · material-agreement (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Income Attributable to ACHC | $74.7M | Down 66.5% for the nine months ended September 30, 2025, from $223.0M in 2024. |
| Revenue | $2.49B | Up 4.7% for the nine months ended September 30, 2025, from $2.38B in 2024. |
| Transaction, Legal and Other Costs | $138.4M | Increased 705% for the nine months ended September 30, 2025, from $17.2M in 2024. |
| Net Income Attributable to ACHC (Q3) | $36.2M | Down 46.8% for the three months ended September 30, 2025, from $68.1M in 2024. |
| Long-term Debt | $2.28B | Increased from $1.88B at December 31, 2024, to September 30, 2025. |
| Interest Expense, Net | $100.9M | Increased from $86.3M for the nine months ended September 30, 2024, to 2025. |
| Salaries, Wages and Benefits | $1.36B | Increased from $1.27B for the nine months ended September 30, 2024, to 2025. |
| Total Assets | $6.41B | Increased from $5.96B at December 31, 2024, to September 30, 2025. |
| Common Stock Shares Outstanding | 90,431,462 | At September 30, 2025, down from 91,775,264 at December 31, 2024. |
| Diluted EPS | $0.82 | Down from $2.42 for the nine months ended September 30, 2024, to 2025. |
| Net Income | $75.3M | Decreased from $80.1M in prior year period for six months ended June 30, 2025. |
| Revenue Growth | 5.1% | Year-over-year increase in revenue for the six months ended June 30, 2025. |
| Inman Litigation Jury Award | $30.0M | Total compensatory and punitive damages awarded on July 7, 2023. |
| Term Loan A Facility | $1.0B | Part of the new credit facility established on February 28, 2025. |
| Revolving Credit Facility | $750.0M | Part of the new credit facility established on February 28, 2025. |
Forward-Looking Statements
- {"claim":"FMR LLC will maintain its significant stake in Acadia Healthcare, signaling continued confidence in the company's long-term growth.","entity":"FMR LLC","targetDate":"Next 12-18 months","confidence":"medium"}
- {"claim":"Wellington Management Group LLP will continue to be a significant institutional holder of Acadia Healthcare Company, Inc. stock.","entity":"Wellington Management Group LLP","targetDate":"December 29, 2024","confidence":"high"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Acadia Healthcare Company, Inc. (ACHC)?
Acadia Healthcare Company, Inc. has 41 recent SEC filings from Jan 2024 to Mar 2026, including 19 8-K, 9 SC 13G/A, 6 10-Q. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of ACHC filings?
Across 41 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 38 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Acadia Healthcare Company, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Acadia Healthcare Company, Inc. (ACHC) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Acadia Healthcare Company, Inc.?
Key financial highlights from Acadia Healthcare Company, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for ACHC?
The investment thesis for ACHC includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Acadia Healthcare Company, Inc.?
Key executives identified across Acadia Healthcare Company, Inc.'s filings include Inman Litigation, Christopher H. Hunter, Abigail P. Johnson.
What are the main risk factors for Acadia Healthcare Company, Inc. stock?
Of ACHC's 29 assessed filings, 1 were flagged high-risk, 9 medium-risk, and 19 low-risk.
What are recent predictions and forward guidance from Acadia Healthcare Company, Inc.?
Recent forward-looking statements from Acadia Healthcare Company, Inc. include guidance on {"claim":"FMR LLC will maintain its significant stake in Acadia Healthcare, signaling continued confidence in the compan and 1 other predictions.